REGULATORY INTELLIGENCE·Recall
Glaxosmithkline Consumer Healthcare Holdings Initiates Class II Recall of Advil Liqui-Gel Minis Due to Labeling Omission
Glaxosmithkline Consumer Healthcare Holdings voluntarily recalled 446,628 bottles of Advil Liqui-Gel Minis (Ibuprofen 200 mg) across the U.S. and Puerto Rico. This Class II recall, initiated March 16, 2020, was due to the omission of critical safety warnings on the Drug Facts Panel. The event highlights the imperative for rigorous quality control in labeling to prevent market disruptions and ensure patient safety.
90-Day Activity